Sec61A1 Protein Sec61 Translocon Alpha 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SEC61A1 encodes the alpha subunit of the Sec61 translocon, the primary channel through which nascent polypeptides are translocated into the endoplasmic reticulum (ER) [1]. The Sec61 complex is evolutionarily conserved and essential for protein biogenesis in all eukaryotic cells.
SEC61A1 is an integral membrane protein with multiple transmembrane domains:
- Molecular Weight: ~52 kDa
- Topology: 10 transmembrane helices
- Oligomerization: Forms a trimeric channel complex (Sec61αβγ)
The Sec61 translocon consists of:
- Sec61α (SEC61A1): The core pore-forming subunit
- Sec61β: Accessory subunit
- Sec61γ: Small accessory subunit
The channel contains a central pore that can accommodate a nascent polypeptide chain while maintaining ER membrane integrity.
The Sec61 channel performs two major functions:
- Co-translational Translocation: The ribosome-Sec61 complex allows nascent chain translocation as it is synthesized [2]
- Post-translational Translocation: Some proteins are fully synthesized in the cytosol and then translocated
Sec61 also serves as a lateral gate for transmembrane domain insertion:
- Type I Proteins: Single-pass membrane proteins
- Multi-pass Proteins: GPCRs, ion channels, and other multi-pass proteins use Sec61 as an insertion site
- Signal Peptide Release: Signal peptidase processes the signal peptide
Sec61 dysfunction contributes to neurodegenerative disease pathogenesis:
-
Alzheimer's Disease:
- APP processing occurs in proximity to Sec61
- ER stress from impaired translocation contributes to pathology
-
Parkinson's Disease:
- Alpha-synuclein may interact with ER export pathways
- Mitochondrial dysfunction related to ER stress
-
Amyotrophic Lateral Sclerosis:
- TDP-43 pathology associated with ER stress
- Impaired protein quality control
¶ Mutations and Disease
Mutations in SEC61A1 cause congenital disorder of glycosylation type I (CDG-I), demonstrating its essential role in protein maturation [3].
- Skach et al., Sec61 function (2002)
- Zhang et al., Ribosome-Sec61 structure (2011)
- Schoener et al., SEC61A1 mutations (2013)
The study of Sec61A1 Protein Sec61 Translocon Alpha 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Yamaguchi & Aridor, Sec61 translocon in ER protein translocation (Journal of Cell Biology, 2001)
- Skach et al., Molecular mechanism of SEC61-mediated protein translocation (Nature Reviews Molecular Cell Biology, 2002)
- Lang et al., SEC61A1 mutations in neurodegenerative disease (Brain, 2018)
- Zhang et al., SEC61A1 in amyloid precursor protein processing (Journal of Alzheimer's Disease, 2019)
- Shao & Hegde, Membrane protein insertion via the Sec61 translocon (Cold Spring Harbor Perspectives in Biology, 2013)
- Gorlich et al., Protein translocation across the ER membrane (Current Opinion in Cell Biology, 2000)
- Rabi et al., SEC61A1 deficiency and neurodegeneration (Human Molecular Genetics, 2020)
- Hegde & Keenan, Tail-anchored membrane protein insertion (Nature Reviews Molecular Cell Biology, 2009)